{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:23:02Z","timestamp":1768713782020,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22277002"],"award-info":[{"award-number":["22277002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["Z220014"],"award-info":[{"award-number":["Z220014"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bmc.2025.118217","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T21:59:21Z","timestamp":1745791161000},"page":"118217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development of a PSMA and EphA2 dual-receptor-activated fluorescent probe for wash-free prostate cancer cell imaging"],"prefix":"10.1016","volume":"125","author":[{"given":"Xingcan","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5186-4990","authenticated-orcid":false,"given":"Xing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118217_b0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bmc.2025.118217_b0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12951-020-00650-1","article-title":"Multifunctional nanobubbles carrying indocyanine green and paclitaxel for molecular imaging and the treatment of prostate cancer","volume":"18","author":"Lan","year":"2020","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.bmc.2025.118217_b0015","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2967\/jnumed.120.257238","article-title":"Current and Emerging Clinical Applications of PSMA PET Diagnostic Imaging for Prostate Cancer","volume":"62","author":"Farolfi","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmc.2025.118217_b0020","doi-asserted-by":"crossref","first-page":"30S","DOI":"10.2967\/jnumed.115.169599","article-title":"Evaluation of Prostate Cancer with 11C-Acetate PET\/CT","volume":"57","author":"Spick","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmc.2025.118217_b0025","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2025.118217_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116810","article-title":"Optimization of ODAP-Urea-based dual-modality PSMA targeting probes for sequential PET-CT and optical imaging","volume":"66","author":"Li","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2025.118217_b0035","doi-asserted-by":"crossref","first-page":"10409","DOI":"10.1021\/jacs.9b04412","article-title":"Fluorescence Detection of Prostate Cancer by an Activatable Fluorescence Probe for PSMA Carboxypeptidase Activity","volume":"141","author":"Kawatani","year":"2019","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2025.118217_b0040","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1038\/s41467-021-25746-6","article-title":"A prostate-specific membrane antigen activated molecular rotor for real-time fluorescence imaging","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2025.118217_b0045","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.162907","article-title":"Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer","volume":"8","author":"Sayar","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.bmc.2025.118217_b0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41585-024-00900-z","article-title":"Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer","volume":"22","author":"Bakht","year":"2025","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.bmc.2025.118217_b0055","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1097\/RLU.0000000000002750","article-title":"Potential Causes of False-Negative Interpretations in 68Ga-PSMA PET\/CT for the Detection of Local and Recurrent Prostate Cancer: An Underexposed Issue","volume":"45","author":"Yakar","year":"2020","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.bmc.2025.118217_b0060","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1158\/1078-0432.CCR-20-3310","article-title":"Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET","volume":"27","author":"Wang","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2025.118217_b0065","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2967\/jnumed.117.198929","article-title":"PET Using a GRPR Antagonist (68)Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients","volume":"59","author":"Zhang","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmc.2025.118217_b0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13045-020-00944-9","article-title":"Targeting EphA2 in cancer","volume":"13","author":"Xiao","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.bmc.2025.118217_b0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T","article-title":"Overexpression of the EphA2 tyrosine kinase in prostate cancer","volume":"41","author":"Walker-Daniels","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.bmc.2025.118217_b0080","doi-asserted-by":"crossref","first-page":"14623","DOI":"10.1021\/acs.jmedchem.3c01135","article-title":"Development of a (18)F-Labeled Bicyclic Peptide Targeting EphA2 for Molecular Imaging of PSMA-Negative Prostate Cancer","volume":"66","author":"Gan","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118217_b0085","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2967\/jnumed.123.266183","article-title":"Design, Preclinical Evaluation, and Clinical Translation of (68)Ga-FAPI-LM3, a Heterobivalent Molecule for PET Imaging of Nasopharyngeal Carcinoma","volume":"65","author":"Zhao","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmc.2025.118217_b0090","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2967\/jnumed.117.199877","article-title":"Dual-Targeted Molecular Imaging of Cancer","volume":"59","author":"Ehlerding","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmc.2025.118217_b0095","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1021\/acs.jmedchem.4c02768","article-title":"PSMA and SSTR2 Dual-Targeting Theranostic Agents for Neuroendocrine-Differentiated Prostate Cancer (NEPC)","volume":"68","author":"Jin","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118217_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116236","article-title":"Novel estrogen receptor \u03b2\/histone deacetylase dual-targeted near-infrared fluorescent probes as theranostic agents for imaging and treatment of prostate cancer","volume":"268","author":"He","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118217_b0105","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1021\/acs.molpharmaceut.2c01000","article-title":"Preclinical Evaluation of a Fibroblast Activation Protein and a Prostate-Specific Membrane Antigen Dual-Targeted Probe for Noninvasive Prostate Cancer Imaging","volume":"20","author":"Wang","year":"2023","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmc.2025.118217_b0110","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-022-01042-7","article-title":"Targeting signaling pathways in prostate cancer: mechanisms and clinical trials","volume":"7","author":"He","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmc.2025.118217_b0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-022-00272-w","article-title":"Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance","volume":"6","author":"Ge","year":"2022","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.bmc.2025.118217_b0120","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2016.02.022","article-title":"Fluorescence optical imaging in anticancer drug delivery","volume":"226","author":"Etrych","year":"2016","journal-title":"J Controll Release"},{"key":"10.1016\/j.bmc.2025.118217_b0125","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1152\/physrev.00049.2010","article-title":"A molecular imaging primer: modalities, imaging agents, and applications","volume":"92","author":"James","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bmc.2025.118217_b0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.addr.2016.08.010","article-title":"Activatable fluorescence: From small molecule to nanoparticle","volume":"113","author":"Luby","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmc.2025.118217_b0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1021\/ar1000633","article-title":"Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications","volume":"44","author":"Kobayashi","year":"2011","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.bmc.2025.118217_b0140","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/cmmi.1636","article-title":"Bioresponsive probes for molecular imaging: concepts and in vivo applications","volume":"10","author":"van Duijnhoven","year":"2015","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.bmc.2025.118217_b0145","doi-asserted-by":"crossref","first-page":"15300","DOI":"10.1021\/acs.analchem.9b04552","article-title":"Design, Synthesis, and Characterization of Bis(7-(N-(2-morpholinoethyl)sulfamoyl)benzo[c][1,2,5]oxadiazol-5-yl)sulfane for Nonprotein Thiol Imaging in Lysosomes in Live Cells","volume":"91","author":"Alqahtani","year":"2019","journal-title":"Anal Chem"},{"key":"10.1016\/j.bmc.2025.118217_b0150","doi-asserted-by":"crossref","first-page":"6877","DOI":"10.1021\/ac301306s","article-title":"Benzofurazan sulfides for thiol imaging and quantification in live cells through fluorescence microscopy","volume":"84","author":"Li","year":"2012","journal-title":"Anal Chem"},{"key":"10.1016\/j.bmc.2025.118217_b0155","doi-asserted-by":"crossref","DOI":"10.1021\/cbmi.4c00063","article-title":"Tuning SBDs as Endoplasmic Reticulum Self-Targeting Fluorophores and Its Application for Zn2+ Tracking in ER Stress","author":"Li","year":"2024","journal-title":"Chem Biomed Imaging"},{"key":"10.1016\/j.bmc.2025.118217_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116821","article-title":"Discovery of non-substrate, environmentally sensitive turn-on fluorescent probes for imaging HDAC8 in tumor cells and tissue slices","volume":"68","author":"Huang","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2025.118217_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2022.121060","article-title":"Real-time imaging of intracellular cysteine level fluctuations during Cu(2+) or H(2)O(2) induced redox imbalance using a turn-on fluorescence sensor","volume":"273","author":"Zhao","year":"2022","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"10.1016\/j.bmc.2025.118217_b0170","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1039\/D1OB01114F","article-title":"Investigation of thiolysis of 4-substituted SBD derivatives and rational design of a GSH-selective fluorescent probe","volume":"19","author":"Yang","year":"2021","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2025.118217_b0175","doi-asserted-by":"crossref","first-page":"11037","DOI":"10.1039\/D0SC03037F","article-title":"A FRET-based fluorescent Zn(2+) sensor: 3D ratiometric imaging, flow cytometric tracking and cisplatin-induced Zn(2+) fluctuation monitoring","volume":"11","author":"Xu","year":"2020","journal-title":"Chem Sci"},{"key":"10.1016\/j.bmc.2025.118217_b0180","doi-asserted-by":"crossref","first-page":"9552","DOI":"10.1002\/chem.201200597","article-title":"Environment-sensitive fluorophores with benzothiadiazole and benzoselenadiazole structures as candidate components of a fluorescent polymeric thermometer","volume":"18","author":"Uchiyama","year":"2012","journal-title":"Chemistry"},{"key":"10.1016\/j.bmc.2025.118217_b0185","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1021\/acs.jmedchem.9b02031","article-title":"(S)-3-(Carboxyformamido)-2-(3-(carboxymethyl)ureido)propanoic Acid as a Novel PSMA Targeting Scaffold for Prostate Cancer Imaging","volume":"63","author":"Duan","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118217_b0190","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1021\/acs.jmedchem.9b02129","article-title":"Identification and Optimization of EphA2-Selective Bicycles for the Delivery of Cytotoxic Payloads","volume":"63","author":"Mudd","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118217_b0195","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.7150\/thno.96641","article-title":"Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptide","volume":"14","author":"El Fakiri","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.bmc.2025.118217_b0200","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1007\/s00259-021-05486-x","article-title":"(68)Ga-labeled ODAP-Urea-based PSMA agents in prostate cancer: first-in-human imaging of an optimized agent","volume":"49","author":"Duan","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.bmc.2025.118217_b0205","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-0716-3327-4_15","article-title":"Characterization of Small Molecule-Protein Interactions Using SPR Method","volume":"2690","author":"Sun","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bmc.2025.118217_b0210","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.7150\/jca.14120","article-title":"Vasculogenic Mimicry in Prostate Cancer: The Roles of EphA2 and PI3K","volume":"7","author":"Wang","year":"2016","journal-title":"J Cancer"},{"key":"10.1016\/j.bmc.2025.118217_b0215","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1471-4159.2004.02358.x","article-title":"NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR","volume":"89","author":"Olszewski","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmc.2025.118217_b0220","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.chembiol.2015.12.003","article-title":"A Bright Future for Precision Medicine: Advances in Fluorescent Chemical Probe Design and Their Clinical Application","volume":"23","author":"Garland","year":"2016","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.bmc.2025.118217_b0225","article-title":"Chemical Approaches to Optimize the Properties of Organic Fluorophores for Imaging and Sensing","volume":"63","author":"Jiang","year":"2024","journal-title":"Angewandte Chemie (International Ed. in English)"},{"key":"10.1016\/j.bmc.2025.118217_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.01.060","article-title":"Receptor-ligand interactions for optimized endocytosis in targeted therapies","author":"Sung","year":"2025","journal-title":"J Control Release"},{"key":"10.1016\/j.bmc.2025.118217_b0235","first-page":"4055","article-title":"Constitutive and antibody-induced internalization of prostate-specific membrane antigen","volume":"58","author":"Liu","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2025.118217_b0240","doi-asserted-by":"crossref","first-page":"46974","DOI":"10.1074\/jbc.M208495200","article-title":"An ephrin mimetic peptide that selectively targets the EphA2 receptor","volume":"277","author":"Koolpe","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2025.118217_b0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042120","article-title":"A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo","volume":"7","author":"Petty","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2025.118217_b0250","doi-asserted-by":"crossref","first-page":"10241","DOI":"10.1021\/acs.chemrev.9b00008","article-title":"Understanding Cell Penetration of Cyclic Peptides","volume":"119","author":"Dougherty","year":"2019","journal-title":"Chem Rev"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625001580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625001580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:09:18Z","timestamp":1746835758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625001580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":50,"alternative-id":["S0968089625001580"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118217","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a PSMA and EphA2 dual-receptor-activated fluorescent probe for wash-free prostate cancer cell imaging","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118217"}}